Citigroup’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-280,324
| Closed | -$15.4M | – | 5869 |
|
|
2022
Q2 | $15.4M | Buy |
280,324
+262,834
| +1,503% | +$14.5M | 0.01% | 666 |
|
|
2022
Q1 | $561K | Buy |
17,490
+10,146
| +138% | +$325K | ﹤0.01% | 2779 |
|
|
2021
Q4 | $160K | Buy |
+7,344
| New | +$160K | ﹤0.01% | 3721 |
|
|
2020
Q4 | – | Sell |
-36
| Closed | – | – | 5336 |
|
|
2020
Q3 | $0 | Hold |
36
| – | – | ﹤0.01% | 5201 |
|
|
2020
Q2 | $0 | Hold |
36
| – | – | ﹤0.01% | 5212 |
|
|
2020
Q1 | $0 | Sell |
36
-1
| -3% | – | ﹤0.01% | 5264 |
|
|
2019
Q4 | $0 | Hold |
37
| – | – | ﹤0.01% | 5255 |
|
|
2019
Q3 | $1K | Hold |
37
| – | – | ﹤0.01% | 5054 |
|
|
2019
Q2 | $1K | Hold |
37
| – | – | ﹤0.01% | 5067 |
|
|
2019
Q1 | $3K | Hold |
37
| – | – | ﹤0.01% | 4950 |
|
|
2018
Q4 | $2K | Hold |
37
| – | – | ﹤0.01% | 4899 |
|
|
2018
Q3 | $2K | Hold |
37
| – | – | ﹤0.01% | 4938 |
|
|
2018
Q2 | $4K | Buy |
+37
| New | +$4K | ﹤0.01% | 4791 |
|
|
2017
Q1 | – | Sell |
-3
| Closed | – | – | 4954 |
|
|
2016
Q4 | $0 | Sell |
3
-119
| -98% | – | ﹤0.01% | 5004 |
|
|
2016
Q3 | $9K | Buy |
122
+20
| +20% | +$1.48K | ﹤0.01% | 4497 |
|
|
2016
Q2 | $8K | Sell |
102
-4
| -4% | -$314 | ﹤0.01% | 4606 |
|
|
2016
Q1 | $29K | Sell |
106
-20
| -16% | -$5.47K | ﹤0.01% | 4475 |
|
|
2015
Q4 | $76K | Buy |
126
+69
| +121% | +$41.6K | ﹤0.01% | 3780 |
|
|
2015
Q3 | $47K | Buy |
+57
| New | +$47K | ﹤0.01% | 3594 |
|